5F-NNE1
![]() | |
Systematic (IUPAC) name | |
---|---|
1-(5-Fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide | |
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 1445580-60-8 |
ChemSpider | 29341632 |
UNII |
3T22QDP4D9 ![]() |
Chemical data | |
Formula | C24H23FN2O |
Molar mass | 374.45 g/mol |
| |
|
5F-NNE1 (also known as 5F-NNEI and 5F-MN-24) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2] Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-NNE1 may release 1-naphthylamine, a known carcinogen.
Legality
Sweden's public health agency suggested classifying 5F-NNE1 as hazardous substance on November 10, 2014.[3]
See also
References
- ↑ "5F-NNEI". Southern Association of Forensic Scientists. Retrieved 24 July 2015.
- ↑ Ariane Wohlfarth, Marisol S. Castaneto, Mingshe Zhu, Shaokun Pang, Karl B. Scheidweiler, Robert Kronstrand, Marilyn A. Huestis (May 2015). "Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA". The AAPS Journal 17 (3): 660–677. doi:10.1208/s12248-015-9721-0. PMID 25721194.
- ↑ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 24 July 2015.
This article is issued from Wikipedia - version of the Thursday, March 31, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.